Stearoyl-L-carnitine chloride
Modify Date: 2025-08-20 15:37:38
Stearoyl-L-carnitine chloride structure
|
Common Name | Stearoyl-L-carnitine chloride | ||
|---|---|---|---|---|
| CAS Number | 32350-57-5 | Molecular Weight | 464.122 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C25H50ClNO4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Stearoyl-L-carnitine chlorideStearoyl-L-carnitine chloride is an endogenous long-chain acylcarnitine. Stearoyl-L-carnitine chloride is a less potent inhibitor of GlyT2. Stearoyl-L-carnitine chloride inhibits glycine responses by 16.8% at concentrations up 3 μM[1][2]. |
| Name | (2R)-3-Carboxy-N,N,N-trimethyl-2-(stearoyloxy)-1-propanaminium chloride |
|---|---|
| Synonym | More Synonyms |
| Description | Stearoyl-L-carnitine chloride is an endogenous long-chain acylcarnitine. Stearoyl-L-carnitine chloride is a less potent inhibitor of GlyT2. Stearoyl-L-carnitine chloride inhibits glycine responses by 16.8% at concentrations up 3 μM[1][2]. |
|---|---|
| Related Catalog | |
| Target |
GlyT2 |
| In Vitro | Stearoyl-L-carnitine (0.01-10 μM) inhibits glycine (30 μM) transports by 16.8% at concentrations up 3 μM in Xenopus laevis oocytes[2]. Stearoyl-L-carnitine (500 μM; 30 min) inhibits Na+-dependent [3H]carnitine (20 nM) uptake by ~50% in HPCT cells[3]. |
| In Vivo | Stearoyl-L-carnitine is significantly decreased in Alzheimer's disease (AD), mild cognitive impairment (MCI) and subjective memory complaint (SMC)[1]. |
| References |
| Molecular Formula | C25H50ClNO4 |
|---|---|
| Molecular Weight | 464.122 |
| Exact Mass | 463.342834 |
| Hazard Codes | Xi |
|---|
| 1-Propanaminium, 3-carboxy-N,N,N-trimethyl-2-[(1-oxooctadecyl)oxy]-, chloride, (2R)- (1:1) |
| (2R)-3-Carboxy-N,N,N-trimethyl-2-(stearoyloxy)-1-propanaminium chloride |
| (2R)-3-carboxy-N,N,N-trimethyl-2-(octadecanoyloxy)propan-1-aminium chloride |